4/A - Compute Health Acquisition Corp. (0001828608) (Issuer)

4 - Compute Health Acquisition Corp. (0001828608) (Issuer)

4 - Compute Health Acquisition Corp. (0001828608) (Issuer)

Allurion to commence trading on August 2, 2023 on the New York Stock Exchange under ticker symbol "ALUR" Business combination with Compute Health Acquisition Corp. completed on August 1, 2023 Net proceeds from transaction total approximately $100 million, significantly higher than the $70 million minimum closing condition Allurion Technologies, Inc. ("Allurion"), a company dedicated to ending obesity, today announced the completion of its previously announced business combination (the "Business Combination") with Compute Health Acquisition Corp. ("Compute Health") (NYSE:CPUH), a publicly traded special purpose acquisition company. Allurion is expected to commence trading of its common

Allurion Technologies, Inc. ("Allurion"), a company dedicated to ending obesity, and Compute Health Acquisition Corp. ("Compute Health") (NYSE:CPUH) today announced that Compute Health's stockholders have approved all proposals related to the previously announced business combination (the "Business Combination") between Compute Health and Allurion at a special meeting of Compute Health's stockholders held on July 28, 2023. Approximately 99.8% of the votes cast on the Business Combination proposals by holders of Compute Health's common stock, representing approximately 87.7% of Compute Health's outstanding common stock, voted to approve the Business Combination, including approximately 58.2%

Warrant Holders Approve Warrant Agreement Amendment Compute Health Acquisition Corp. ("Compute Health") (NYSE:CPUH, CPUH WS, CPUH.U))) today announced that at a special meeting of Compute Health's warrant holders held today (the "Warrant Holder Meeting"), the previously announced proposal to amend the warrant agreement that governs the outstanding warrants of Compute Health (the "Warrant Amendment") was approved by its warrant holders. Approximately 89% of the votes cast at the Warrant Holder Meeting, including votes cast by holders of approximately 55% of Compute Health's outstanding public warrants, voted to approve the Warrant Amendment. The Warrant Holder Meeting was held, and the W

Serial healthcare entrepreneur Douglas Hudson appointed to Board of Directors Tomer Stavitsky joins as VP of Corporate Development to lead M&A strategy focused on Artificial Intelligence (AI) Allurion Technologies, Inc. ("Allurion"), a company dedicated to ending obesity, is pleased to announce two major additions to the team. Douglas Hudson has been appointed to the Board of Directors of Allurion Technologies Holdings, Inc., effective as of the anticipated consummation of the proposed business combination (the "Business Combination") between Allurion and Compute Health Acquisition Corp. ("Compute Health") (NYSE:CPUH), and Tomer Stavitsky has joined as Allurion's new Vice President of C

Stockholders of Record as of July 3, 2023 are Eligible to Vote at Special Meeting on July 28, 2023 Allurion Technologies, Inc. ("Allurion"), a company dedicated to ending obesity, and Compute Health Acquisition Corp. ("Compute Health") (NYSE:CPUH) , remind Compute Health's stockholders to vote in favor of their previously announced proposed business combination (the "Business Combination") at a Special Meeting (the "Special Meeting") for stockholders of record as of July 3, 2023. All Compute Health stockholders, regardless of number of shares held, are encouraged to vote "FOR" the Business Combination and related proposals described in the definitive proxy statement and prospectus previou

Warrant Holder Meeting to Take Place on July 25, 2023 as Previously Announced All Compute Health Acquisition Corp. Stockholders Encouraged to Vote "FOR" all Proposals to be Presented at the Warrant Holder Meeting Allurion Technologies, Inc. ("Allurion"), a company dedicated to ending obesity, and Compute Health Acquisition Corp. ("Compute Health") (NYSE:CPUH) today announced updated terms to the warrant agreement (the "Warrant Agreement") that governs the outstanding warrants of Compute Health. Subject to the approval of the warrant holders of Compute Health, which will be sought at the Warrant Holder Meeting (as defined below), the Warrant Agreement terms will be amended to: (i) prov

Allurion has created the world's first full stack weight-loss platform featuring the Allurion Gastric Balloon, the world's first and only swallowable, procedure-less gastric balloon for weight loss and has seen revenues increase 100% year over year from 2016 to 2021 Allurion's technology platform includes the Allurion Virtual Care Suite, a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring with a proprietary behavior change program To date, over 100,000 patients in over 50 countries across six continents have been treated with the Allurion Program, experiencing weight loss, on average, of 30 pounds per patient The proposed transaction includes a fully

15-12G - Compute Health Acquisition Corp. (0001828608) (Filer)

25-NSE - Compute Health Acquisition Corp. (0001828608) (Subject)

DEFA14A - Compute Health Acquisition Corp. (0001828608) (Filer)

8-K - Compute Health Acquisition Corp. (0001828608) (Filer)

425 - Compute Health Acquisition Corp. (0001828608) (Subject)

8-K - Compute Health Acquisition Corp. (0001828608) (Filer)

425 - Compute Health Acquisition Corp. (0001828608) (Subject)

DEFA14A - Compute Health Acquisition Corp. (0001828608) (Filer)

8-K - Compute Health Acquisition Corp. (0001828608) (Filer)

425 - Compute Health Acquisition Corp. (0001828608) (Subject)

SC 13G/A - Compute Health Acquisition Corp. (0001828608) (Subject)

SC 13G/A - Compute Health Acquisition Corp. (0001828608) (Subject)

SC 13G - Compute Health Acquisition Corp. (0001828608) (Subject)

SC 13G - Compute Health Acquisition Corp. (0001828608) (Subject)

SC 13G - Compute Health Acquisition Corp. (0001828608) (Subject)